Form D · Biotechnology
OUROTECH, INC.- PEAR BIO
London, X0 · CIK 0001890185
Offering snapshot reported Apr 14, 2023 · SEC filing
- Reported sold
- $14.2M Offering amount: $16.1M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 3, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2023 | Initial | $14,151,725 | No comparison | 12 | SEC filing |
| Oct 29, 2021 | Initial | $4,586,498 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-478861
Total amount sold includes $994,680.00 of convertibles.
Source: Form D, filed Apr 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Uzma Choudry | Director |
| Rob Kniaz | Director |
| Zhi Yuan Lin | Director |
| Duleeka Ranatunga | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
84 Wood Lane
London, X0, W12 0BZ
London, X0, W12 0BZ